DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Vassal G, Giammarile F, Brooks M. et al.
A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Societe Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG).
Eur J Cancer 2008;
44: 2453-2460
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.